BANK OF AMERICA CORP /DE/ - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q3 2023$1,999
+6.1%
8,1920.0%0.00%
Q2 2023$1,884
+37.6%
8,1920.0%0.00%
Q1 2023$1,369
+39.3%
8,1920.0%0.00%
Q4 2022$983
-1.7%
8,1920.0%0.00%
Q3 2022$1,000
-94.4%
8,192
-26.4%
0.00%
Q2 2022$18,0000.0%11,132
+3.8%
0.00%
Q1 2022$18,000
+12.5%
10,721
+30.9%
0.00%
Q4 2021$16,000
-5.9%
8,1920.0%0.00%
Q3 2021$17,000
-10.5%
8,1920.0%0.00%
Q2 2021$19,000
+18.8%
8,1920.0%0.00%
Q1 2021$16,0000.0%8,1920.0%0.00%
Q4 2020$16,000
+1500.0%
8,192
+1538.4%
0.00%
Q3 2020$1,0000.0%5000.0%0.00%
Q2 2020$1,0000.0%5000.0%0.00%
Q1 2020$1,0000.0%5000.0%0.00%
Q4 2019$1,0000.0%5000.0%0.00%
Q3 2019$1,0000.0%5000.0%0.00%
Q2 2019$1,0000.0%5000.0%0.00%
Q1 2019$1,0005000.0%0.00%
Q4 2018$0
-100.0%
5000.0%0.00%
Q3 2018$1,0000.0%5000.0%0.00%
Q2 2018$1,0000.0%5000.0%0.00%
Q1 2018$1,0005000.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 152,764$365,0000.50%
Ikarian Capital, LLC 800,811$1,915,0000.16%
DAFNA Capital Management LLC 306,980$734,0000.15%
PVG ASSET MANAGEMENT CORP 12,155$29,050,0000.09%
Phoenix Holdings Ltd. 1,060,300$2,534,0000.05%
Virtu Financial LLC 39,618$95,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 89,689$214,0000.01%
HBK Sorce Advisory LLC 22,000$53,0000.00%
MORGAN STANLEY 693,420$1,658,0000.00%
Bank of New York Mellon Corp 25,000$60,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders